These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2055603)

  • 1. C1 inhibitor: different mechanisms of reaction with complement component C1 and C1s.
    Hortin GL; Trimpe BL
    Immunol Invest; 1991 Feb; 20(1):75-82. PubMed ID: 2055603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.
    Arlaud GJ; Reboul A; Sim RB; Colomb MG
    Biochim Biophys Acta; 1979 Jan; 576(1):151-62. PubMed ID: 760802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
    Sim RB; Arlaud GJ; Colomb MG
    Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 14. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
    Aubert B; Chesne S; Arlaud GJ; Colomb MG
    Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.